Nov 16, 2022 / 01:35PM GMT
Annabel Samimy - Stifel Financial Corp. - Analyst
So good morning, everyone, and welcome to the Clearside Biomedical presentation. I'm Annabel Samimy, a biopharma analyst at Stifel. And it's our pleasure to have CEO, George Lasezkay here today with us as well as Tom Ciulla, Chief Medical Officer. So why don't we just start by kicking it off with a five-minute overview to get everyone on the same page.
George Lasezkay - Clearside Biomedical, Inc. - President & CEO
Sure. Thanks, Annabel. And it's great to be here. Appreciate the time. Appreciate the invite, and we're happy to be here. You've been with us a long time.
Annabel Samimy - Stifel Financial Corp. - Analyst
A little bit, yeah.
George Lasezkay - Clearside Biomedical, Inc. - President & CEO
And you've been with us a long time. But if you go back, what we've been trying to do at the company for a number of years is come up with a way that's safe, repeatable, and in-office procedure to administer drugs into the
Clearside Biomedical Inc at Stifel Healthcare Conference Transcript
Nov 16, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers